Texas Yale Capital Corp. Sells 1,000 Shares of MetLife, Inc. $MET

Texas Yale Capital Corp. lessened its holdings in shares of MetLife, Inc. (NYSE:MET) by 10.4% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 8,636 shares of the financial services provider’s stock after selling 1,000 shares during the period. Texas Yale Capital Corp.’s holdings in MetLife were worth $695,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Diamond Hill Capital Management Inc. purchased a new position in MetLife during the 1st quarter valued at $336,965,000. Nuveen LLC bought a new position in shares of MetLife in the first quarter worth about $312,946,000. Price T Rowe Associates Inc. MD lifted its holdings in MetLife by 7.4% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 26,488,146 shares of the financial services provider’s stock valued at $2,126,734,000 after buying an additional 1,824,907 shares in the last quarter. Alyeska Investment Group L.P. purchased a new stake in MetLife in the 1st quarter valued at about $68,030,000. Finally, AQR Capital Management LLC grew its stake in MetLife by 85.0% in the 1st quarter. AQR Capital Management LLC now owns 1,321,881 shares of the financial services provider’s stock worth $104,270,000 after acquiring an additional 607,333 shares in the last quarter. 94.99% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

MET has been the subject of several research analyst reports. Cowen reaffirmed a “buy” rating on shares of MetLife in a research note on Friday, August 22nd. Morgan Stanley lifted their target price on MetLife from $94.00 to $97.00 and gave the company an “overweight” rating in a research report on Tuesday, October 7th. Piper Sandler downgraded MetLife from an “overweight” rating to a “neutral” rating and set a $84.00 price target on the stock. in a research report on Friday, September 19th. Keefe, Bruyette & Woods decreased their price objective on MetLife from $94.00 to $92.00 and set an “outperform” rating for the company in a report on Monday, August 11th. Finally, Weiss Ratings reaffirmed a “buy (b)” rating on shares of MetLife in a research note on Wednesday, October 8th. One equities research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $95.18.

MetLife Stock Up 0.2%

Shares of MET stock opened at $76.11 on Friday. The stock’s fifty day moving average price is $80.04 and its 200 day moving average price is $78.79. MetLife, Inc. has a 1-year low of $65.21 and a 1-year high of $89.05. The company has a market cap of $50.62 billion, a price-to-earnings ratio of 12.90, a price-to-earnings-growth ratio of 0.70 and a beta of 0.87. The company has a debt-to-equity ratio of 0.57, a current ratio of 0.16 and a quick ratio of 0.16.

MetLife (NYSE:MET) last issued its quarterly earnings results on Wednesday, November 5th. The financial services provider reported $2.37 earnings per share for the quarter, topping the consensus estimate of $2.30 by $0.07. MetLife had a return on equity of 19.88% and a net margin of 5.83%.The business had revenue of $12.46 billion during the quarter, compared to the consensus estimate of $18.64 billion. During the same quarter last year, the company earned $1.95 earnings per share. The company’s quarterly revenue was down 5.9% on a year-over-year basis. On average, research analysts expect that MetLife, Inc. will post 9.65 earnings per share for the current fiscal year.

MetLife Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 9th. Stockholders of record on Tuesday, November 4th will be paid a dividend of $0.5675 per share. This represents a $2.27 annualized dividend and a dividend yield of 3.0%. The ex-dividend date is Tuesday, November 4th. MetLife’s payout ratio is presently 42.75%.

About MetLife

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.